Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4899795 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL2461505 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL13985320 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL18937991 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL13239640 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL23097490 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL16209782 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL9682360 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL20691112 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL14228823 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025083657-A1 | LIPID COMPOUND AND COMPOSITION FOR TISSUE-SPECIFIC DELIVERY OF ACTIVE SUBSTANCE | 한국생명공학연구원 | 2025-04-24 | — | — | WO | claimed |
| CN-115353534-A | Colchicine derivative, and preparation and application thereof | 郑州大学第一附属医院 | 2022-11-18 | — | — | CN | claimed |
| US-20210147796-A1 | METHOD FOR REMOVING UNDIFFERENTIATED PLURIPOTENT STEM CELLS | ACADEMIA SINICA (TW) | 2021-05-20 | — | — | US | claimed |
| US-20200290038-A1 | PREFILLED CARTRIDGE | MYCARTIS N.V. (BE) | 2020-09-17 | — | — | US | claimed |
| US-20200147209-A1 | ALUM-CONTAINING COATING FORMULATIONS FOR MICRONEEDLE VACCINE PATCHES | KINDEVA DRUG DELIVERY L.P. | 2020-05-14 | — | — | US | claimed |
| EP-3634425-A1 | METHOD FOR REMOVING UNDIFFERENTIATED PLURIPOTENT STEM CELLS | Academia Sinica (TW) | 2020-04-15 | — | — | EP | claimed |
| CN-110772643-A | α -tocopheryl polyethylene glycol succinate modified cardiac glycoside compound prodrug | 沈阳药科大学 | 2020-02-11 | — | — | CN | claimed |
| CN-110772644-A | Polyethylene glycol modified cardiac glycoside compound prodrug and anti-tumor application thereof | 沈阳药科大学 | 2020-02-11 | — | — | CN | claimed |
| EP-3512633-A1 | PREFILLED CARTRIDGE | MyCartis N.V. (BE) | 2019-07-24 | — | — | EP | claimed |
| CN-109806270-A | Urginea maritima glycosides compound is preparing the application in anti-flavivirus infection medicine | 中国医学科学院药物研究所 | 2019-05-28 | — | — | CN | claimed |
| EP-0373038-A2 | New lysosphingolipid derivatives | FIDIA S.p.A. (IT) | 1990-06-13 | — | — | EP | claimed |
| EP-0310519-A1 | Androstane 17-carboxylic-acid esters, their preparation and medicaments containing them | LABORATOIRE NATIVELLE (Société Anonyme) (FR) | 1989-04-05 | — | — | EP | claimed |
| EP-0101659-B1 | 14-AMINO-STEROID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THERAPY | ETABLISSEMENTS NATIVELLE S.A. (FR) | 1986-02-19 | — | — | EP | claimed |
| US-4552868-A | CARDIOTONIC AGENTS | ETABLISSEMENTS NATIVELLE S.A. (FR) | 1985-11-12 | — | — | US | claimed |
| EP-0101659-A2 | 14-Amino-steroid derivatives, process for their preparation and their use in therapy | ETABLISSEMENTS NATIVELLE S.A. (FR) | 1984-02-29 | — | — | EP | claimed |
| EP-0047928-B1 | CARDENOLIDE-BIS-DIGITOXOSIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR UTILIZATION AS MEDICINES | Roche Diagnostics GmbH (DE) | 1983-09-21 | — | — | EP | claimed |
| EP-0047928-A1 | Cardenolide-bis-digitoxoside derivatives, process for their preparation and their utilization as medicines | Roche Diagnostics GmbH (DE) | 1982-03-24 | — | — | EP | claimed |
| US-4184037-A | RADIOIMMUNOASSAY | BURROUGHS WELLCOME CO. (US) | 1980-01-15 | — | — | US | claimed |
| US-4088807-A | AMINO RESINS | NIPPON SHEET GLASS CO., LTD. (JA) | 1978-05-09 | — | — | US | claimed |
| US-3963697-A | Labelled cardiotonic glycosides for use in radioimmunoassay | CURTIS NUCLEAR CORPORATION (US) | 1976-06-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147796-A1 | METHOD FOR REMOVING UNDIFFERENTIATED PLURIPOTENT STEM CELLS | ALPG, UGGT1, GYPA | CHRM5 828/4885CHRM1 988/4885CHRM3 408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.